3GZ-11627-60237
5 vaccinations
16 coded responses
44 check-ins
16 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 564 / MN
- Registered
- 2021-01-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Dose 1 — Pfizer-BioNTech
-
2021-01-24
Registered in v-safe
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Fatigue or tiredness, DiarrheaFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · ChillsFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — day 7, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-05-13
Survey response — 3 months, dose 2MedDRA: Dyspnoea, Fatigue, Hypertension — Feeling: GoodFree text: High blood pressure, mainly systolic. More so to get short of breath. TiredMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Office visit, Taste disorder, Upper respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Taste has been effected. Smell is okay. Upper respiratory problem with congestion for over 2 weeks · Healthcare visit (other): Saw MD twiceMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-19
-
2021-10-15
Dose 3 — Pfizer-BioNTech
-
2022-02-11
Survey response — 12 months, dose 2MedDRA: Dyspnoea, Hypertension, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Heart(hypertension), shortness of breath, digestion, kidney functionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-02-14
Call successfulDoes not wish to fill out VAERS report
-
2022-04-08
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Survey response — day 7, dose 4MedDRA: Unevaluable event — Feeling: GoodFree text: TasteMedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
- 2022-04-29
-
2022-05-06
Survey response — day 28, dose 4MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Either heart or gastric. On going, not relatedMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — day 28, dose 4Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-05-10
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-05-13
- 2022-05-20
-
2022-07-09
Survey response — 3 months, dose 4MedDRA: Cardiac disorder, Chest discomfort — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: Chest and heart issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-07-09
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-07-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-23
Dose 5 — Pfizer-BioNTech
- 2022-09-23
-
2022-09-24
Survey response — days 1–6 daily, dose 5MedDRA: Dyspnoea, Pulmonary hypertension — Feeling: Fair · Fatigue or tirednessFree text: Shortness of breath, Pulmonary hypertensionMedDRA releases: 2024-11 · check-in free text available
- 2022-09-25
-
2022-09-26
Survey response — days 1–6 daily, dose 5MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
-
2022-10-07
Survey response — day 14, dose 5MedDRA: Dyspnoea — Feeling: FairFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Survey response — day 21, dose 5MedDRA: Taste disorder — Feeling: FairFree text: Change in taste of some foods a S in first Covid shotMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
-
2022-10-28
Survey response — day 35, dose 5MedDRA: Muscle spasms — Feeling: Good · Be unable to do your normal daily activitiesFree text: Leg & foot cramps. Maybe cause of a deficiencyMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
- 2022-12-23
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
| 5 | 2022-09-23 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 4 — day 7, dose 2
Systemic reaction (other): No
Release 8 — 3 months, dose 2
Symptoms: High blood pressure, mainly systolic. More so to get short of breath. Tired
Release 9 — 6 months, dose 2
Symptoms: Taste has been effected. Smell is okay. Upper respiratory problem with congestion for over 2 weeks
Healthcare visit (other): Saw MD twice
Release 11 — 12 months, dose 2
Symptoms: Heart(hypertension), shortness of breath, digestion, kidney function
Release 11 — day 7, dose 4
Systemic reaction (other): Taste
Release 11 — day 28, dose 4
Symptoms: Either heart or gastric. On going, not related
Release 12 — 3 months, dose 4
Symptoms: Chest and heart issues
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Shortness of breath, Pulmonary hypertension
Systemic reaction (other): Shortness of breath
Release 12 — day 14, dose 5
Symptoms: Shortness of breath
Release 12 — day 21, dose 5
Symptoms: Change in taste of some foods a S in first Covid shot
Release 12 — day 35, dose 5
Symptoms: Leg & foot cramps. Maybe cause of a deficiency
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Cardiac disorder | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Taste disorder | ✓ | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Upper respiratory tract congestion | ✓ | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pulmonary hypertension | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release